Ophthalmology EBITDA Multiples: What Practices Sell For
Ophthalmology EBITDA multiples are one of the most discussed, and most misunderstood, numbers in practice sales. Owners hear about multiples paid by private equity groups and wonder what their own practice might be worth. Buyers wonder whether those figures apply to the practice in front of them.
The honest answer is that there is no single multiple for ophthalmology. What a practice sells for depends on how its earnings are calculated, who is buying, what is included in the sale and how the deal is structured. This guide explains what drives the multiple and why headline figures can be misleading. It is general information only, and nothing here is a valuation, appraisal or legal, tax or investment advice.
What EBITDA Means in a Practice Sale
EBITDA stands for earnings before interest, taxes, depreciation and amortization. It is used as a rough measure of the cash a business generates from operations, before financing and accounting decisions.
In practice sales, buyers usually work from adjusted EBITDA. Adjustments may include:
- Resetting physician compensation to what the selling doctors will be paid after the sale
- Removing personal or one-time expenses
- Normalizing rent if the owners also own the building
- Accounting for staff or management roles that need to be added
The compensation reset is especially important. If a buyer lowers physician pay after closing, adjusted EBITDA rises, and so does the price. The seller effectively trades future income for proceeds at closing. Understanding that tradeoff is essential before comparing any offer to what the practice earns for its owners today. Our guide on how to value an ophthalmology practice covers valuation methods in more detail.
Why Ophthalmology EBITDA Multiples Vary So Widely
Two practices with similar collections can receive very different offers. Factors that may push a multiple up or down include:
- Size and scale: larger practices with several physicians and locations often attract more buyer interest than single-surgeon practices
- Subspecialty mix: retina, cataract, glaucoma, cornea and comprehensive practices each carry different revenue profiles and risks
- Ancillary services: surgery center interests, optical, diagnostic testing and premium services may add value
- Payer mix: heavy dependence on Medicare can expose earnings to fee schedule changes
- Physician age and retention: buyers value practices where physicians will stay and younger doctors are in place
- Owner dependence: a practice built around one surgeon may be worth less than one with a broad team
- Referral network: stable relationships with optometrists and other referral sources support future volume
- Management and systems: clean financials, strong billing and good reporting reduce buyer risk
Platform vs Add-On Practices
Private equity groups often distinguish between a “platform” practice that anchors a region and smaller “add-on” practices acquired later. Platforms may receive higher multiples because they bring scale, management and infrastructure. Add-ons may receive lower multiples, although they can benefit from joining an established organization.
This is one reason published or rumored multiples can be misleading. A figure paid for a large regional platform may not apply to a smaller practice. Our article on selling an ophthalmology practice to private equity explains how these deals are typically structured.
Headline Multiple vs What the Seller Actually Receives
The multiple quoted in a letter of intent is not the same as the cash a seller receives. A private equity offer may include:
- Cash at closing
- Rollover equity in the buyer’s platform, which carries risk
- Contingent payments tied to future performance, which lenders and buyers may limit
- A lower post-sale compensation arrangement
Taxes, transaction costs and how the price is allocated among assets also affect net proceeds. Comparing offers on an after-tax, after-compensation basis is usually more meaningful than comparing multiples.
How Financing Limits What a Physician Buyer Can Pay
When the buyer is an individual ophthalmologist or a small group, the price is often limited by what a lender will finance. Lenders generally evaluate whether the practice’s cash flow can support the debt payments after paying the buyer a reasonable salary. That means the supportable price for a physician buyer may differ from what a private equity group might offer.
Our guide on how much you can borrow to buy an ophthalmology practice explains how lenders approach that question. Physician buyers may also be able to offer advantages that are harder to measure, such as continuity for staff and patients and preserving the practice’s independence.
How Sellers Can Improve Their Multiple
Owners who plan to sell in the coming years may be able to strengthen their position by documenting earnings clearly, reducing owner dependence, recruiting and retaining associates, diversifying referral sources and addressing older equipment. Our article on how to increase ophthalmology practice value before a sale covers these steps in more detail.
An independent advisor can help an owner understand how different buyers might view the practice and compare offers objectively. Starting that work well before a sale gives owners time to make improvements that buyers and lenders can see in the financial statements, rather than relying on projections or promises about future performance.
Final Thoughts
Ophthalmology EBITDA multiples are a useful shorthand, but they rarely tell the whole story. The definition of earnings, the type of buyer, the structure of the offer and what a lender will finance all shape what a practice actually sells for. Owners and buyers who understand those drivers are better positioned to negotiate a fair deal.
US Medical Funding helps ophthalmologists finance acquisitions and evaluate practice transitions. Learn more about our ophthalmology practice acquisition financing and our advisory and consulting services.
